BLACK WEEKSVialer −15% · kit −10% · övrigt −5%med kodFri frakt inom Tyskland från €200

Den här sidan har översatts automatiskt och kan innehålla fel. Har du svenska som modersmål? Vi tar gärna emot din feedback och dina förbättringar.Skicka feedback

The Peptide Desk The Peptide Desk
BPC + TB Oral Blend, produktfoto
Healing Oral

BPC + TB Oral Blend

Healing Oral

  • Skickas från Tyskland

Beställning

Styckpris - Fri frakt inom Tyskland från 200 € under Black Weeks
  • DHL med spårning
  • Diskret förpackning

4.6 av 5 på Trustpilot73 omdömen

I korthet

BPC + TB Oral Blend i siffror

Nyckeltalen från vårt lexikon.

Hela lexikonartikeln
Class
Oral healing blendBPC + TB
Use
Oraltablet
Sizes
1 mg1 size in the shop

What studies show

The source in the lexicon
  1. Review of the structure, function and clinical potential of thymosin beta-4 (TB-500) (opens in a new tab)

    Crockford et al., Annals of the New York Academy of Sciences, 2010

Det finns ännu ingen labbanalys för BPC + TB Oral Blend. Rösta på denLåt testa själv, vi betalar halvaAlla labbanalyser

Kunskap

Allt om BPC + TB Oral Blend

FAQ

Vanliga frågor

Källor till varje svar: lexikonartikel

Har du fortfarande en fråga?

Skriv till oss, vårt team hjälper dig.

Are there studies on this tablet?

No. As of 26 October 2026 there is no study of BPC-157 and TB-500 together taken by mouth, neither on ClinicalTrials.gov nor in PubMed. Everything here comes from studies on the single compounds.

Do both work better together?

That is not established. In the only study of both peptides together (Achilles tendon in 32 rats, injected into the abdominal cavity) each on its own was linked to better tendon tissue, significantly above all with TB-500, which also raised tensile strength. The combination gave no advantage over either alone. The authors suspect shared signalling pathways.

What is TB-500?

TB-500 is sold as a fragment of thymosin beta-4. Thymosin beta-4 binds the structural protein actin in cells and is linked to cell migration, new vessel formation and tissue repair. A 2026 review finds hardly any solid human safety data for TB-500.

Are the peptides absorbed by mouth?

For BPC-157 there are hints from animal studies: according to a review it is stable in human gastric juice and worked via the drinking water in rats. There are no blood measurements after oral dosing. For TB-500 by mouth there are no data at all.

Which trials are running on the components?

As of 26 October 2026 no trial in which a component is injected is recruiting. Announced are a phase 1 trial of BPC-157 under the skin after shoulder surgery and a third phase 2 trial of thymosin beta-4 after heart attack. Two phase 2 trials of thymosin beta-4 after heart attack are completed. A study of gummies with BPC-157 is completed, results are still missing.

Which side effects are known?

None for the tablet. No treatment-related side effects occurred in the three small human studies on BPC-157, but the certainty is very low. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. One review warns of risks from unregulated manufacturing.

Relaterat

Relaterade produkter